Hints and tips:
Showing results for Amylin Pharamaceuticals LLC
...Shares in Amylin rose $8.38 to $23.77 at the close in New York....
...Last year, US regulators failed to approve Bydureon, a diabetes drug Lilly developed with Amylin Pharmaceuticals, and asked the company to work on further studies....
International Edition